Abstract
It is desirable to develop an in vitro system to predict the activity of antineoplastic agents in man, much as bacterial culture and sensitivity techniques are used in the treatment of infectious disease. Such a test would allow the rapid screening of potential anticancer agents for activity and might allow the selection of appropriate chemotherapy for an individual patient’s tumor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cline M: In Vitro test systems for anticancer drugs. N Engl J Med 280:955, 1969.
Eagle H, Foley GE: Cytotoxicity in human cell cultures as a primary screen for the detection of antitumor agents. Cancer Res 18: 1017–1025, 1958.
Dendy PP, Bozman G, Wheeler TK: In Vitro screening test for malignant human tumors before chemotherapy. Lancet 2: 68–72, 1970.
Lickiss JN, Cane KA, Baikie AG: In Vitro drug selection in antineoplastic chemotherapy. Eur J Cancer 10: 809–814, 1974.
Wright JC, Cobb JP, Gumport SL, Safad D, Walker DG, Golomb FM: Further investigation of the relation between the clinical and tissue culture response to chemotherapeutic agents on human cancer. Cancer 15: 284–293, 1962.
Hurley J, Yount L: Selection of anticancer drug for palliation using tissue culture sensitivity studies. Am J Surgery 109: 39–42, 1965.
Holmes HL, Little JM: Tissue culture microtest for predicting response of human cancer to chemotherapy. Lancet 2: 985–987, 1974.
Durkin WJ, Ghanta VK, Balch CM, Davis DW, Hiramoto RN: A methodological approach to the prediction of anticancer drug effect in humans. Cancer Res 39: 402–407, 1979.
Weisenthal LM, Marsden J: A novel dye exclusion assay for predicting response to cancer chemotherapy. Proc Am Assoc Cancer Res and ASCO 22: 155, 1981.
DiPaola JA: Analysis of an individual chemotherapy assay system. Natl Cancer Inst Monogr 34: 240–245, 1971.
Kondo T: Prediction of response of tumor and host to cancer chemotherapy. Natl Cancer Inst Monogr 34: 251–256, 1971.
McGuire WL: Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol 5: 428–433, 1978.
Smyth JF, Robins AB, Leese CL: The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukemia. Eur J Cancer 12: 567–573, 1976.
Kessel D: Relevance of In Vitro tests for predicting responsiveness to antitumor agents. Natl Cancer Inst Monogr 34: 138–145, 1971.
Livingston RB: Depression of thymidine labeling index In Vitro predicts effects of chemotherapy in patients. Proc Am Assoc Cancer Res and ASCO 20: 317, 1979.
McDonald GO, Mclver JM, Llamas AJ, Sky–Peck HH: Tumor cytotoxicity: quantitative changes in DNA synthesis as an indicator. Arch Surg 92: 541–547, 1966.
Cline M: Prediction of in vivo cytotoxicity of chemotherapeutic agents by their effect on malignant leukocytes In Vitro. Blood 30: 176–187, 1967.
Roper P, Drewinko B: Comparison of In Vitro methods to determine drug induced cell lethality. Cancer Res 36: 2182–2188, 1976.
Fjelde A: Human tumor cells in tissue culture. Cancer 8: 845–851, 1955.
Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, Mabry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562–4569, 1976.
Pickard RG, Cobb LM, Steel GG: The growth kinetics of xenografts of human colorectal tumors in immune deprived mice. Br J Cancer 31: 36–45, 1975.
Smith IE, Courtenay VD, Gordon MY: A colony forming assay for human tumor xenografts using agar in diffusion chambers. Br J Cancer 34: 476–484, 1976.
Lamerton LF, Steel GG: Growth kinetics of human large bowel cancer growing in immune deprived mice and some chemotherapeutic observations. Cancer 36: 2431–2436, 1975.
Berry RJ, Laing AH, Wells J: Fresh explant culture of human tumors In Vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer 31: 218–227, 1975.
Fuskova T, Fuska J, Ivanitskaya LP, Makwkho LV: Different sensitivity to antibiotics of the established intermittent In Vitro - in vivo tumor cell line in comparison with primary culture. Neoplasma 24: 239–242, 1977.
Steel GG. Cell kinetics and cell survival. In: Medical oncology - Medical aspects of malignant disease, Bagshawe KD (ed). Oxford: Blackwell, 1975, pp 49–66.
Pike BL, Robinson WA: Human bone marrow colony growth in agargel. J Cell Physiol 76: 77–81, 1970.
Tepperman AJ, Curtin J, McCulloch EA: Erythropoietic colonies in culture of human marrow. Blood 44: 659–669, 1974.
Hewitt HB, Wilson CW: A survival curve for mammalian leukemic cells irradiated In Vitro. Br J Cancer 13: 69–75, 1959.
Hill RP, Bush RS: A lung colony assay to determine the radiosensitivity of the cells of a solid tumor. Int J Radiat Biol 15: 435–44, 1969.
Bruce WR, Meeker BE, Valeriote FA: Comparison of the sensitivity of normal and transplanted lymphoma colony forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37: 233–45, 1966.
Wilcox WS, Griswold DP, Laster WR, Schabel FM, Skipper HF: Experimental evaluation of potential anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. Cancer Chemother Rep 47: 27–39, 1965.
Brown CH, Carbone PP: In Vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst 46: 989–1000, 1971.
Hermens AF, Barendsen GW: Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. Eur J Cancer 5: 173–189, 1969.
Park CH, Bergsagel DE, McCulloch EA: Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 46: 411–422, 1971.
Ogawa W, Bergsagel DE, McCulloch EA. Chemotherapy of mouse myeloma: qualitative cell cultures predictive of response in vivo. Blood 41: 7–15, 1973.
McAllister RM, Reed G: Colony growth in agar of cells from neoplastic and nonneoplastic tissues of children. Pediat Res 2: 356–360, 1968.
Altman AJ, Crussi FG, Rierden WJ, Baehner RL: Growth of rhabdomyosarcoma colonies from pleural fluids. Cancer Res 35: 1809–1812, 1975.
Hamburger AW, Salmon SE, Kim MB, Trent JM, Soehnlen BJ, Alberts DS, Schmidt HJ: Direct cloning of human ovarian carcinoma cell in agar. Cancer Res 38: 3438–3444, 1978.
Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197: 461–463, 1977.
Hamburger A, Salmon SE: Primary bioassay of human myeloma stem cells. J Clin Invest 60: 846–854, 1977.
Costachel O, Fadei L, Badea E: Tumor cell suspension culture on non–adhesive substratum. Z Krebsforsch 72: 24–31, 1969.
Salmon SE, Buick RM. Preparation of permanent slides of soft agar colonies of hematopoietic and tumor stem cells. Cancer Res 39: 1133–1136, 1979.
Von Hoff DD, Harris GJ, Johnson G, Glaubiger D: Initial experience with the human tumor stem cell assay system: potentials and problems. In: Human tumor cloning, Salmon SE (ed). New York: Alan Liss, 1980, pp 113–124.
Harris GJ, Zeagler J, Hode KA, Casper J, Von Hoff DD: Ultrastructural analysis of colonies growing in a human tumor cloning system. Cancer (in press).
Trent JM: Cytogenetic analysis of human tumor cells cloned in agar. In: Cloning of human tumor stem cells, Salmon SE (ed). New York: Alan Liss, 1980, pp 165–179.
Buick RN, Stanisic TH, Fry SE, Salmon SE, Trent JM, Krasovich P: Development of an agar/methyl cellulose clonogenic assay for progenitor cells in transitional cell carcinoma of the bladder. Cancer Res 39: 5051–5056, 1979.
Brodeur GM, Sekhon GS, Goldstein MN: Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256–2263, 1977.
Von Hoff DD: New leads from the laboratory for treating testicular cancer. In: Therapeutic progress in ovarian cancer, testicular cancer and sarcomas, Van Oosterom (ed.). The Hague: Martinus Nijhoff, 1980, p225–234.
Leibovitz A: In: Human tumor cells In Vitro, Fogh J (ed). New York: Plenum, 1975, pp 23–50.
Mavligit GM, Hersh EM, McBride CM: Lymphocyte blastogenic responses to autochthonous viable and nonviable human tumor cells. J Natl Cancer Inst 51: 337–343, 1973.
Mattern J, Kaufmann M, Wayss K, Volm M: Studies on the drug sensitivity of short term cultured tumor cell suspensions. In: Human tumors in short term culture, Dendy PP (ed). New York: Academic Press, 1976, pp 301–310.
Pretlow TG, Jones CM, Pretlow TP: Separation of tumor cells by density gradient centrifugation: recent work with human tumors and discussion of the kind of quantitation needed in cell separation experiments. Biophys Chem 5: 99–106, 1976.
Rockwell S: In vivo–In Vitro tumor systems: new models for studying the response of tumors to therapy. Lab Anim Sci 27:831–851, 1977.
Daniels A, Daniels J, Luck EE: Agarose matrix and enzyme disaggregation improve efficiency of the soft agar chemosensitivity test. Proc Am Assoc Cancer Res and ASCO 22: 155, 1981.
VanWezel AL, VanHemert PA, Parisius W, Cucakovich NB, Macmorine HG: Improved cell dispersal method by low temperature incubation of tissue in trypsincitrate solution. Appl Microbiol 24: 506–507, 1972.
Pretlow TG, Brattain MG, Kreisberg JI: Separation and characterization of epithelial cells from prostates and prostatic carcinoma: a review. Cancer Treat Rep 61: 153–156, 1977.
Brattain MG, Pretlow TP, Pretlow TG: Cell fractionation of large bowel cancer. Cancer 40: 2479–2480, 1977.
Kimball PM, Brattain MG, Pitts AM: A soft agar procedure measuring growth of human colonic carcinoma. Br J Cancer 37: 1015–1019, 1978.
Slocum HK, Pavelic ZP, Rustum YM, Creaven PJ, Karakousis C, Takita H, Greco WR: Characterization of cells obtained by medical and enzymatic means from human melanoma and sarcoma and lung tumors. Cancer Res 41: 1428–1434, 1981.
Freshney RI: Tumor cells disaggregated in collagenase. Lancet 2: 488–489, 1972.
Twentyman PR: Sensitivity to 1-3-bis (2-chlorethyl)-1-nitrosourea and l-(2-chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea of the EmTG tumor in vivo as determined by both tumor volume and response and In Vitro plating assay. Cancer Res 38: 2395–2400, 1978.
Hodges GM: An overview of tissue culture procedures in tumor biopsy studies. In: Human tumors in short term culture, Dendy PP (ed). New York: Academic Press, 1976, pp 3–14.
Ham RG: Unique requirements of clonal growth. J Natl Cancer Inst 53: 1459–1463, 1974.
Pretlow TG, Weiss EE, Zettergres JG: Problems connected with the separation of different kinds of cells. Int Rev Exp Pathol 14: 91–205, 1975.
Von Hoff DD, Casper J, Bradley E, Trent JM, Hodach A, Reichert C, Makuch R, Altman A: Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res 40:3591– 3597, 1980.
Mattox DE, Von Hoff DD: In Vitro stem cell assay in head and neck squamous carcinoma. Ann Surg 140: 527–530, 1980.
Von Hoff DD, Weisenthal LM, Ihde DC, Mathews MJ, Layard M, Makuch R: Growth of lung cancer colonies from bronchial washings. Cancer 48: 400–403, 1981.
Pollard EB, Tio F, Whitecar JP, Coltman CA, Jr, Von Hoff DD: Utilization of a soft agar system to monitor for marrow involvement with small cell carcinoma of the lung. Proc Am Assoc Cancer Res and ASCO 21: 192, 1980.
Salmon SE, Hamburger AW, Soehnlen BS, Durie BGM, Alberts DS, Moon TE: Quantitations of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321–1327, 1978.
Salmon SE, Soehnlen BJ, Durie BGM, Alberts DS, Meyskens FL, Chen HSG, Moon TE: Clinical correlation of drug sensitivity in tumor stem cell assay. Proc Am Assoc Cancer Res and ASCO 20: 340, 1979.
Von Hoff DD, Casper J, Bradley E, Sandbach J, Jones D, Makuch R: Association between human tumor colony forming assay results and response of an individual patient’s tumor to chemotherapy. Am J Med 70: 1027–1032, 1981.
Von Hoff DD, Page C, Harris G, Clark G, Cowan J, Coltman CA: Prospective clinical trial of a human tumor cloning system. Proc Am Assoc Cancer Res and ASCO 22: 154, 1981.
Alberts DS, Chen HSG, Young L, Moon TE, Leigh SA, Surwit EA, Salmon SE: Improved survival for relapsing ovarian cancer patients using the human tumor stem cell assay. Proc Am Assoc Cancer Res and ASCO 22: 462, 1981.
Von Hoff DD, Cowan JD, Harris G, Reisdorf G: Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol 6: 265–271, 1981.
Blum RH, Carter SK: Adriamycin: a new antitumor drug with significant clinical activity. Ann Intern Med 80: 249–259, 1974.
Salmon SE, Alberts D, Meyskens F, Durie B, Jones S, Soehnler B, Young L: A new concept: In Vitro trial with the human tumor stem cell assay (HTSCA). Proc Am Assoc Cancer Res and ASCO 21: 329, 1980.
Von Hoff DD, Rozencweig M, Muggia FM: Evaluation of cytotoxic drugs. Cancer Treat Rev 6: 1–8, 1979.
Von Hoff DD, Rozencweig M, Soper W, Helman LJ, Davis HL, Penta JS, Muggia FM: Whatever happened to NSC “—”? An analysis of discontinued anticancer agents. Cancer Treat Rep 61: 759–768, 1977.
Von Hoff DD, Gutterman J, Portnoy B, Coltman CA: Human tumor cloning system as a bioassay for interferon. Cancer Chemother and Pharm (in press).
Cowan JD, Von Hoff DD: Use of a human tumor stem cell assay to screen retinoids for antineoplastic activity. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy 20: 29, 1980.
Cowan JD, Coltman CA, Jr, Von Hoff DD: Use of the human tumor cloning system to evaluate cytotoxic activity of misonidazole. Proc Am Assoc Cancer Res and ASCO 22: 233, 1981.
Von Hoff DD, Coltman CA, Jr, Forseth B: Activity of mitoxantrone in a human tumor cloning system: leads for phase II trials in man. Cancer Res 41: 1853–1855, 1981.
Von Hoff DD, Coltman CA, Jr, Forseth B: Activity of 9–10 anthracenedicarboxaldehyde bis (4,5-dihydro-IH-imidazol-2-yl)hydrozone) dihydrochloride (CL 216,942) in a human tumor cloning system: leads for phase II trials in man. Cancer Chemother and Pharm 6: 141–144, 1981.
Kern DH, Campbell MA, Worth GD, Morton DL: Cloning efficiencies and drug sensitivities of freshly prepared suspensions, cryopreserved cells and cell lines derived from human solid tumors. Proc Am Assoc Cancer Res and ASCO 22: 69, 1981.
Tannock I: Cell kinetics and chemotherapy: a critical review. Cancer Treat Rep 62:1117– 1133, 1978.
Silver RT, Young RC, Holland JF: Some new aspects of modern cancer chemotherapy. Am J Med 63: 772–787, 1977.
Valeriote FA, Edelstein MB: The role of cell kinetics in cancer chemotherapy. Semin Oncol 4: 217–226, 1977.
Shackney SE, McCormack GW, Cuchural GJ: Growth rate patterns of solid tumors and their relation to responsiveness to therapy. Ann Int Med 89: 107–121, 1978.
Elson DL, Livingston RB, Coltman CA, Jr, Von Hoff DD: Labeling index depression in human tumor cells cultured in double-layer agar: a potential chemosensitivity assay. Proc Am Assoc Cancer Res and ASCO 21: 164, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Cowan, J.D., Von Hoff, D.D. (1983). The Human Tumor Cloning Assay: An In Vitro Assay for Antitumor Activity in Solid Tumors. In: Muggia, F.M. (eds) Cancer Chemotherapy 1. Cancer Treatment and Research, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3903-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3903-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3905-2
Online ISBN: 978-1-4613-3903-8
eBook Packages: Springer Book Archive